“Final Report of a Phase II Trial of Nimotuzumab in the Treatment of Refractory and Relapsed High-Grade Gliomas in Children and Adolescents”. 2009. Hematology Meeting Reports (formerly Haematologica Reports) 1 (6). https://doi.org/10.4081/hmr.v1i6.675.